Condition
Hormone Receptor Negative Breast Carcinoma clinical trials and research
As of November 12, 2026, Find a Trial lists 5 Hormone Receptor Negative Breast Carcinoma clinical trials that are recruiting, at sites in 2 countries (most in United States (5), South Korea (1)). By phase: Phase 2 (2), Phase 1/2 (1), Phase 1 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 5Clinical trials
- 2Countries
Newest Hormone Receptor Negative Breast Carcinoma clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Adaptive biomarker-driven therapies for metastatic breast cancer | Phase 2 | New Haven, Connecticut and 5 other locations | Recruiting | Jan 14, 2026 |
| Evaluating NKT3964 for Adults with Advanced Solid Tumors | Phase 1 | Little Rock, Arkansas and 20 other locations | Recruiting | Sep 19, 2024 |
| Platform program for evaluating treatments in metastatic HER2-positive breast cancer | Phase 1/2 | Birmingham, Alabama and 9 other locations | Recruiting | May 22, 2023 |
| Biobehavioral stress reduction for patients with triple negative breast cancer | — | Cleveland, Ohio and 1 other locations | Recruiting | Jan 10, 2023 |
| Treatment for male breast cancer using endocrine therapy | Phase 2 | Washington D.C., District of Columbia and 8 other locations | Recruiting | Aug 15, 2022 |
All recruiting trials (5)
-
Adaptive biomarker-driven therapies for metastatic breast cancer
This trial tests whether matching targeted drug combinations to tumor biomarkers helps people with ER+/HER2- or triple-negative metastatic breast cancer who are starting second-line treatment.
-
Evaluating NKT3964 for Adults with Advanced Solid Tumors
This study is testing a new drug called NKT3964 to see if it can safely help adults with advanced solid tumors, like ovarian or triple-negative breast cancer, after other treatments have failed.
-
Platform program for evaluating treatments in metastatic HER2-positive breast cancer
This study is testing different new treatments for people with advanced HER2-positive breast cancer to see which ones work best before moving them to larger trials.
-
Biobehavioral stress reduction for patients with triple negative breast cancer
This study is testing a stress reduction program for people who have just been diagnosed with triple negative breast cancer to see if it helps them feel better and cope with their situation.
-
Treatment for male breast cancer using endocrine therapy
This study is testing different combinations of hormone therapy for men with early to mid-stage breast cancer to see which one works best compared to the usual treatment.
Related topics
Quick answers
How many Hormone Receptor Negative Breast Carcinoma clinical trials are recruiting right now?
5, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 2 countries. The most sites are in United States (5 trials), South Korea (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 2, Phase 1/2: 1, Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.